Assenagon Asset Management S.A. Cytom X Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

$60.5 Billion
Q2 2025

A detailed history of Assenagon Asset Management S.A. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 720,020 shares of CTMX stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

720,020

Previous 711,454 1.2%

Holding current value

$1.71 Million

Previous $455,000 259.12%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	BUY	$0.43 - $2.99 $3,683 - $25,612	8,566 Added 1.2%	720,020 $1.63 Million
Q1 2025 Apr 15, 2025	BUY	$0.58 - $1.14 $64,730 - $127,228	111,604 Added 18.61%	711,454 $455,000
Q4 2024 Jan 14, 2025	SELL	$0.86 - $1.29 $898,113 - $1.35 Million	-1,044,318 Reduced 63.52%	599,850 $617,000
Q3 2024 Oct 23, 2024	BUY	$1.12 - $1.51 $454,349 - $612,560	405,669 Added 32.75%	1,644,168 $1.94 Million
Q2 2024 Jul 18, 2024	BUY	$1.21 - $5.13 $1.01 Million - $4.28 Million	833,825 Added 206.05%	1,238,499 $1.51 Million
Q4 2023 Jan 17, 2024	SELL	$1.07 - $1.55 $22,734 - $32,932	-21,247 Reduced 4.99%	404,674 $627,000
Q3 2023 Nov 06, 2023	SELL	$1.26 - $1.87 $305,059 - $452,747	-242,111 Reduced 36.24%	425,921 $549,000
Q1 2023 Apr 18, 2023	SELL	$1.48 - $2.88 $365,364 - $710,979	-246,868 Reduced 26.98%	668,032 $1.01 Million
Q4 2022 Jan 12, 2023	SELL	$1.19 - $1.91 $179,085 - $287,439	-150,492 Reduced 14.13%	914,900 $1.46 Million
Q3 2022 Oct 27, 2022	BUY	$1.23 - $1.97 $1.31 Million - $2.1 Million	1,065,392 New	1,065,392 $1.55 Million
Q4 2021 Feb 01, 2022	SELL	$3.87 - $7.39 $107,485 - $205,249	-27,774 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$4.32 - $6.43 $2.01 Million - $2.99 Million	-465,239 Reduced 94.37%	27,774 $141,000
Q2 2021 Jul 15, 2021	BUY	$6.33 - $9.91 $1.83 Million - $2.86 Million	288,872 Added 141.51%	493,013 $3.12 Million
Q1 2021 Apr 26, 2021	SELL	$6.6 - $9.0 $96,505 - $131,598	-14,622 Reduced 6.68%	204,141 $1.58 Million
Q4 2020 Feb 01, 2021	BUY	$6.47 - $7.9 $296,888 - $362,507	45,887 Added 26.54%	218,763 $1.43 Million
Q3 2020 Oct 07, 2020	SELL	$6.55 - $8.83 $529,397 - $713,675	-80,824 Reduced 31.86%	172,876 $1.15 Million
Q2 2020 Jul 21, 2020	BUY	$7.4 - $14.64 $1.88 Million - $3.71 Million	253,700 New	253,700 $2.11 Million
Q1 2020 Apr 17, 2020	SELL	$3.61 - $8.6 $810,950 - $1.93 Million	-224,640 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$5.17 - $8.91 $768,985 - $1.33 Million	148,740 Added 195.97%	224,640 $1.87 Million
Q3 2019 Oct 16, 2019	SELL	$7.38 - $12.25 $357,930 - $594,125	-48,500 Reduced 38.99%	75,900 $560,000
Q2 2019 Aug 12, 2019	BUY	$9.35 - $11.41 $1.16 Million - $1.42 Million	124,400 New	124,400 $1.4 Million
Q4 2018 Jan 23, 2019	SELL	$12.69 - $18.61 $249,206 - $365,463	-19,638 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$18.04 - $26.41 $354,269 - $518,639	19,638 New	19,638 $363,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

44.1M

Call Options Held

8.9K

Put Options Held

47.9K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $157M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Cytom X Therapeutics, Inc. Transaction History